181 related articles for article (PubMed ID: 18549332)
1. Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, Italy.
Caraglia M; Marra M; Budillon A
Expert Opin Biol Ther; 2008 Jul; 8(7):1031-5. PubMed ID: 18549332
[TBL] [Abstract][Full Text] [Related]
2. Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, Italy.
Caraglia M; Marra M; Budillon A
Expert Opin Biol Ther; 2008 Jun; 8(6):845-54. PubMed ID: 18476796
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
Garg T; Bhandari S; Rath G; Goyal AK
J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
Denora N; Trapani A; Laquintana V; Lopedota A; Trapani G
Curr Top Med Chem; 2009; 9(2):182-96. PubMed ID: 19200004
[TBL] [Abstract][Full Text] [Related]
6. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
8. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors.
Bhujbal SV; de Vos P; Niclou SP
Adv Drug Deliv Rev; 2014 Apr; 67-68():142-53. PubMed ID: 24491927
[TBL] [Abstract][Full Text] [Related]
9. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
10. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
11. Advances in targeting strategies for nanoparticles in cancer imaging and therapy.
Yhee JY; Lee S; Kim K
Nanoscale; 2014 Nov; 6(22):13383-90. PubMed ID: 25273283
[TBL] [Abstract][Full Text] [Related]
12. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in nanomedicine and survivin targeting in brain cancers.
Mazur J; Roy K; Kanwar JR
Nanomedicine (Lond); 2018 Jan; 13(1):105-137. PubMed ID: 29161215
[TBL] [Abstract][Full Text] [Related]
15. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular Nanomedicine - An Overview.
Sekhon BS
Curr Drug Targets; 2015; 16(13):1407-28. PubMed ID: 25090984
[TBL] [Abstract][Full Text] [Related]
17. Direct attachment of nanoparticle cargo to Salmonella typhimurium membranes designed for combination bacteriotherapy against tumors.
Kazmierczak R; Choe E; Sinclair J; Eisenstark A
Methods Mol Biol; 2015; 1225():151-63. PubMed ID: 25253255
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic nanomedicine for brain cancer.
Tzeng SY; Green JJ
Ther Deliv; 2013 Jun; 4(6):687-704. PubMed ID: 23738667
[TBL] [Abstract][Full Text] [Related]
19. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
Muthu MS; Singh S
Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
[TBL] [Abstract][Full Text] [Related]
20. Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas.
Nguyen J; Hossain SS; Cooke JRN; Ellis JA; Deci MB; Emala CW; Bruce JN; Bigio IJ; Straubinger RM; Joshi S
J Neurooncol; 2017 May; 133(1):77-85. PubMed ID: 28421460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
